<DOC>
	<DOCNO>NCT01374776</DOCNO>
	<brief_summary>Effect intravenous iron substitution ( iron carboxymaltose ( FerinjectÂ® ) , total dose 15 mg/ kg ( maximal dose : 1000mg ) 250 ml 0.9 % NaCl ; intravenous infusion 20 min ) non-anemic premenopausal woman iron deficiency Primary objective : - Mitochondrial capacity ( Phosphocreatine Recovery rate assess 31P-MR-spectroscopy low leg muscle ) Secondary objective : - Maximal oxygen uptake graded cycling exercise test time exhaustion submaximal power constant-load cycling exercise test - Plantarflexor muscle fatiguability assess isokinetic dynamometry - Trial medicinal product</brief_summary>
	<brief_title>Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance In Non Anemic Premenopausal Women With Low Ferritin Levels</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<criteria>Inclusion criterion : INCLUSION CRITERIA Healthy female subject , Age &gt; 18 year , premenopausal , regularly menstruate BMI 1825 kg/m2 . Serum ferritin level &lt; 15ug/ml Recreationally active = 1.5 h/w structure activity Adequate contraception study period Informed consent Exclusion criterion : EXCLUSION CRITERIA Anemia Hb level &lt; 120 g/l Known hypersensitivity iron carboxymaltose , iron sucrose iron sulfate Intake iron preparation ( also multivitamins contain iron ) last 8 week start trial protocol Pregnancy lactation Any cardiovascular pulmonary disease Any orthopaedic rheumatologic disease affect exercise performance Presence muscle disease Acute chronic infection/inflammation malignancy Known mental disorder ( e.g . depression ) Intake concurrent medication , except oral contraceptive CRP &gt; 10 mg/l TSH normal range Elevated CK ( &gt; 167 U/l ) Any concurrent medical condition ( ) , view investigator , would prevent compliance participation jeopardize health patient . Participation therapeutic trial within previous month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>